Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MonoSol Rx, a developer of PharmFilm technology and a drug delivery company specialising in proprietary pharmaceutical film products, has received US patent No 7,824,588 from the US Patent and Trademark Office (USPTO) for the company's film products and methods of their preparation.
Subscribe to our email newsletter
PharmFilm is designed to benefit patients by improving the convenience, efficacy, and compliance of new and currently marketed drugs, MonoSol Rx said.
MonoSol Rx president and CEO Mark Schobel sad that their patented PharmFilm and production technologies are very important to ensuring that drug containing films are manufacturable, content uniform, stable and deliver the in-vivo performance that is expected from each and every dose.
"Importantly, this patent also signals to the entire pharmaceutical industry that PharmFilm is an ideal vehicle for delivering a variety of dosage strengths and sensitive prescription drug targets, including peptides and proteins as well as small molecules," Schobel said.